Indication
Wiskott-Aldrich syndrome
Wiskott-Aldrich syndrome is a rare, X-linked primary immunodeficiency disorder primarily affecting males, caused by hemizygous pathogenic variants in the *WAS* gene. Read more about Wiskott-Aldrich syndrome
46 drugs 18 manufacturers
Drugs that treat it
Common Wiskott-Aldrich syndrome therapies.
GAMMAGARD LIQUID (immune globulin,gamm(IgG)/glycine/IgA greater than 50 mcg/mL)
GAMMAGARD S-D (immune globulin,gamm(IgG)/glycine/glucose/IgA 0 to 50 mcg/mL)
HYQVIA (immune globulin,gamma(IgG) human/hyaluronidase, human recomb)
HYQVIA IG COMPONENT (immune globulin,gamm(IgG)/glycine/IgA greater than 50 mcg/mL)
GAMMAGARD LIQUID (immune globulin,gamm(IgG)/glycine/IgA greater than 50 mcg/mL)
GAMMAGARD S-D (immune globulin,gamm(IgG)/glycine/glucose/IgA 0 to 50 mcg/mL)
HYQVIA (immune globulin,gamma(IgG) human/hyaluronidase, human recomb)
HYQVIA IG COMPONENT (immune globulin,gamm(IgG)/glycine/IgA greater than 50 mcg/mL)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonWiskott-Aldrich syndrome is a rare, X-linked primary immunodeficiency disorder primarily affecting males, caused by hemizygous pathogenic variants in the *WAS* gene.
This gene defect leads to a deficiency or absence of the Wiskott-Aldrich syndrome protein (WASP), an essential regulator of actin cytoskeleton remodeling in hematopoietic lineages.
Pathophysiologically, this impairment disrupts leukocyte activation and signaling, compromises platelet morphogenesis, and leads to accelerated platelet clearance.
Clinically, the condition is classically defined by the triad of microthrombocytopenia with abnormally small platelets, recurrent pyogenic and viral infections due to combined humoral and cellular immunodeficiency, and atopic eczema, alongside heightened lifetime risks for autoimmune cytopenias and hematologic malignancies.
- medlineplus.gov
Wiskott-Aldrich syndrome is a rare, X-linked primary immunodeficiency disorder primarily affecting males, caused by hemizygous pathogenic variants in the *WAS* gene This gene defect leads to a deficiency or absence of the Wiskott-Aldrich syndrome protein (WASP), an essential regulator of actin cytoskeleton remodeling in hematopoietic lineages Pathophysiologically, this impairment disrupts leukocyte activation and signaling, compromises platelet morphogenesis, and leads to accelerated platelet cl...
- nih.gov
Wiskott-Aldrich syndrome is a rare, X-linked primary immunodeficiency disorder primarily affecting males, caused by hemizygous pathogenic variants in the *WAS* gene Clinically, the condition is classically defined by the triad of microthrombocytopenia with abnormally small platelets, recurrent pyogenic and viral infections due to combined humoral and cellular immunodeficiency, and atopic eczema, alongside heightened lifetime risks for autoimmune cytopenias and hematologic malignancies
- nih.gov
This gene defect leads to a deficiency or absence of the Wiskott-Aldrich syndrome protein (WASP), an essential regulator of actin cytoskeleton remodeling in hematopoietic lineages Pathophysiologically, this impairment disrupts leukocyte activation and signaling, compromises platelet morphogenesis, and leads to accelerated platelet clearance
- nih.gov
Clinically, the condition is classically defined by the triad of microthrombocytopenia with abnormally small platelets, recurrent pyogenic and viral infections due to combined humoral and cellular immunodeficiency, and atopic eczema, alongside heightened lifetime risks for autoimmune cytopenias and hematologic malignancies
Personalize your experience
Follow Wiskott-Aldrich syndrome and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.